当前蛋白身份:P47929 重新检索
本组结构的主要差异维度
构建体不同 突变/修饰不同 组装状态不同 配体/离子不同 实验环境不同 结构质量指标不同

差异标签只比较当前检索结果;所有PDB和assembly原始记录仍分别保留。

相关结构差异明细

一行代表一个 PDB 条目中的一个 biological assembly;同一蛋白的多个单体会分别列出。

PDB 条目 Assembly / 聚集状态 构建体 突变与修饰 配体、离子与非聚合物 实验方法 实验环境 结构质量
1BKZ CRYSTAL STRUCTURE OF HUMAN GALECTIN-7 提交 1998-07-13 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 1–135(135 aa)
链 B 1–135(135 aa)
未记录 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 8.1;CRYSTALS WERE GROWN USING THE HANGING DROP METHOD FROM DROPS CONTAINING 9 MG/ML PROTEIN AT PH 8.1 IN 50 MM SODIUM PHOSPHATE BUFFER, 0.3 M SODIUM CHLORIDE, 20 MM IMIDAZOLE, AND 8.5% PEG 3350. DROPS WERE EQUILIBRATED AGAINST RESERVOIRS CONTAINING 50 MM SODIUM PHOSPHATE BUFFER, 0.3 M SODIUM CHLORIDE, 20 MM IMIDAZOLE, AND 17% PEG 3350., vapor diffusion - hanging drop
分辨率 1.90 Å R-free 0.260
2GAL CRYSTAL STRUCTURE OF HUMAN GALECTIN-7 IN COMPLEX WITH GALACTOSE 提交 1998-07-13 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 1–135(135 aa)
链 B 1–135(135 aa)
未记录 GAL beta-D-galactopyranose × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 8.1;CRYSTALS WERE GROWN USING THE HANGING DROP METHOD FROM DROPS CONTAINING 9 MG/ML PROTEIN AT PH 8.1 IN 50 MM SODIUM PHOSPHATE BUFFER, 0.3 M SODIUM CHLORIDE, 20 MM IMIDAZOLE, 8.5% PEG 3350 AND 25 MM GALACTOSE. DROPS WERE EQUILIBRATED AGAINST RESERVOIRS CONTAINING 50 MM SODIUM PHOSPHATE BUFFER, 0.3 M SODIUM CHLORIDE, 20 MM IMIDAZOLE, 17% PEG 3350 AND 50 MM GALACTOSE., vapor diffusion - hanging drop
分辨率 2.00 Å R-free 0.245
3GAL CRYSTAL STRUCTURE OF HUMAN GALECTIN-7 IN COMPLEX WITH GALACTOSAMINE 提交 1998-07-13 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 1–135(135 aa)
未记录 1GN 2-amino-2-deoxy-beta-D-galactopyranose × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 8.1;CRYSTALS WERE GROWN USING THE HANGING DROP METHOD FROM DROPS CONTAINING 9 MG/ML PROTEIN AT PH 8.1 IN 50 MM SODIUM PHOSPHATE BUFFER, 0.3 M SODIUM CHLORIDE, 20 MM IMIDAZOLE, 8.5% PEG 3350 AND 25 MM GALACTOSAMINE. DROPS WERE EQUILIBRATED AGAINST RESERVOIRS CONTAINING 50 MM SODIUM PHOSPHATE BUFFER, 0.3 M SODIUM CHLORIDE, 20 MM IMIDAZOLE, 17% PEG 3350 AND 50 MM GALACTOSAMINE., vapor diffusion - hanging drop
分辨率 1.90 Å R-free 0.258
3GAL CRYSTAL STRUCTURE OF HUMAN GALECTIN-7 IN COMPLEX WITH GALACTOSAMINE 提交 1998-07-13 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 1–135(135 aa)
未记录 1GN 2-amino-2-deoxy-beta-D-galactopyranose × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 8.1;CRYSTALS WERE GROWN USING THE HANGING DROP METHOD FROM DROPS CONTAINING 9 MG/ML PROTEIN AT PH 8.1 IN 50 MM SODIUM PHOSPHATE BUFFER, 0.3 M SODIUM CHLORIDE, 20 MM IMIDAZOLE, 8.5% PEG 3350 AND 25 MM GALACTOSAMINE. DROPS WERE EQUILIBRATED AGAINST RESERVOIRS CONTAINING 50 MM SODIUM PHOSPHATE BUFFER, 0.3 M SODIUM CHLORIDE, 20 MM IMIDAZOLE, 17% PEG 3350 AND 50 MM GALACTOSAMINE., vapor diffusion - hanging drop
分辨率 1.90 Å R-free 0.258
3ZXE Crystal structure of Human Galectin-7 in complex with a galactose- benzylphosphate inhibitor 提交 2011-08-10 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 4–136(133 aa) 片段:RESIDUES 4-136
未记录 PGZ METHYL 2-O-[(S)-(BENZYLOXY)(HYDROXY)PHOSPHORYL]-3-DEOXY-3-{[(4-METHYLPHENYL)CARBONYL]AMINO}-1-THIO-BETA-D-GALACTOPYRANOSIDE × 1 X-RAY DIFFRACTION
X-ray结晶条件 pH 8.5;0.1M BISTRISPROPANE, 20% PEG3350, pH 8.5
分辨率 1.67 Å R-free 0.236
3ZXE Crystal structure of Human Galectin-7 in complex with a galactose- benzylphosphate inhibitor 提交 2011-08-10 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 4–136(133 aa) 片段:RESIDUES 4-136
未记录 PGZ METHYL 2-O-[(S)-(BENZYLOXY)(HYDROXY)PHOSPHORYL]-3-DEOXY-3-{[(4-METHYLPHENYL)CARBONYL]AMINO}-1-THIO-BETA-D-GALACTOPYRANOSIDE × 1 X-RAY DIFFRACTION
X-ray结晶条件 pH 8.5;0.1M BISTRISPROPANE, 20% PEG3350, pH 8.5
分辨率 1.67 Å R-free 0.236
3ZXF High resolution structure of Human Galectin-7 提交 2011-08-10 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 1–136(136 aa)
非标准单体:是(mmCIF未提供具体位点) ACT ACETATE ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 pH 8.1;50MM SODIUM PHOSPHATE, 300 MM NACL, 15% PEG3350, 20MM IMIDAZOLE, pH 8.1
分辨率 1.38 Å R-free 0.226
3ZXF High resolution structure of Human Galectin-7 提交 2011-08-10 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 1–136(136 aa)
非标准单体:是(mmCIF未提供具体位点) 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 pH 8.1;50MM SODIUM PHOSPHATE, 300 MM NACL, 15% PEG3350, 20MM IMIDAZOLE, pH 8.1
分辨率 1.38 Å R-free 0.226
4GAL CRYSTAL STRUCTURE OF HUMAN GALECTIN-7 IN COMPLEX WITH LACTOSE 提交 1998-07-13 Assembly 1 其他组合 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 1–135(135 aa)
链 B 1–135(135 aa)
未记录 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 8.1;CRYSTALS WERE GROWN USING THE HANGING DROP METHOD FROM DROPS CONTAINING 9 MG/ML PROTEIN AT PH 8.1 IN 50 MM SODIUM PHOSPHATE BUFFER, 0.3 M SODIUM CHLORIDE, 20 MM IMIDAZOLE, 8.5% PEG 3350. DROPS WERE EQUILIBRATED AGAINST RESERVOIRS CONTAINING 50 MM SODIUM PHOSPHATE BUFFER, 0.3 M SODIUM CHLORIDE, 20 MM IMIDAZOLE, 17% PEG 3350. GALECTIN-7 CRYSTALS WERE THEN SOAKED WITH 5 MM LACTOSE FOR 2 HRS., vapor diffusion - hanging drop
分辨率 1.95 Å R-free 0.255
4UW3 Human galectin-7 in complex with a galactose based dendron D1. 提交 2014-08-08 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 1–136(136 aa)
未记录 50G DENDRON-D1 × 1 X-RAY DIFFRACTION
X-ray结晶条件 0.05 M BIS TRIS PROPANE PH7, 17 % PEG 3350
分辨率 1.48 Å R-free 0.198
4UW3 Human galectin-7 in complex with a galactose based dendron D1. 提交 2014-08-08 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 1–136(136 aa)
未记录 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 0.05 M BIS TRIS PROPANE PH7, 17 % PEG 3350
分辨率 1.48 Å R-free 0.198
4UW4 Human galectin-7 in complex with a galactose based dendron D2-1. 提交 2014-08-08 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 1–136(136 aa)
未记录 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;289 K;0.05 M BIS TRIS PROPANE PH 7, 17% PEG 3350
分辨率 1.77 Å R-free 0.235
4UW4 Human galectin-7 in complex with a galactose based dendron D2-1. 提交 2014-08-08 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 1–136(136 aa)
未记录 4S0 DENDRON D2-1 × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;289 K;0.05 M BIS TRIS PROPANE PH 7, 17% PEG 3350
分辨率 1.77 Å R-free 0.235
4UW5 Human galectin-7 in complex with a galactose based dendron D2-2. 提交 2014-08-08 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 1–136(136 aa)
未记录 4S0 DENDRON D2-1 × 1 X-RAY DIFFRACTION
X-ray结晶条件 0.05M BIS TRIS PROPANE PH7, 14% PEG 3350
分辨率 2.04 Å R-free 0.319
4UW5 Human galectin-7 in complex with a galactose based dendron D2-2. 提交 2014-08-08 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 1–136(136 aa)
未记录 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 0.05M BIS TRIS PROPANE PH7, 14% PEG 3350
分辨率 2.04 Å R-free 0.319
4UW5 Human galectin-7 in complex with a galactose based dendron D2-2. 提交 2014-08-08 Assembly 3 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 C 1–136(136 aa)
未记录 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 0.05M BIS TRIS PROPANE PH7, 14% PEG 3350
分辨率 2.04 Å R-free 0.319
4UW5 Human galectin-7 in complex with a galactose based dendron D2-2. 提交 2014-08-08 Assembly 4 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 D 1–136(136 aa)
未记录 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 0.05M BIS TRIS PROPANE PH7, 14% PEG 3350
分辨率 2.04 Å R-free 0.319
4UW5 Human galectin-7 in complex with a galactose based dendron D2-2. 提交 2014-08-08 Assembly 5 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 E 1–136(136 aa)
未记录 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 0.05M BIS TRIS PROPANE PH7, 14% PEG 3350
分辨率 2.04 Å R-free 0.319
4UW5 Human galectin-7 in complex with a galactose based dendron D2-2. 提交 2014-08-08 Assembly 6 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 F 1–136(136 aa)
未记录 4S0 DENDRON D2-1 × 1 X-RAY DIFFRACTION
X-ray结晶条件 0.05M BIS TRIS PROPANE PH7, 14% PEG 3350
分辨率 2.04 Å R-free 0.319
4UW6 Human galectin-7 in complex with a galactose based dendron D3 提交 2014-08-08 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 1–136(136 aa)
未记录 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 0.05M BISTRIS PROPANE PH7, 17% PEG 3350
分辨率 1.79 Å R-free 0.251
4UW6 Human galectin-7 in complex with a galactose based dendron D3 提交 2014-08-08 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 1–136(136 aa)
未记录 VV7 DENDRON-D3 × 1 X-RAY DIFFRACTION
X-ray结晶条件 0.05M BISTRIS PROPANE PH7, 17% PEG 3350
分辨率 1.79 Å R-free 0.251
4XBQ Crystal Structure of Human Galectin-7 in Complex with Type 1 N-acetyllactosamine 提交 2014-12-17 Assembly 1 其他组合 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 1–136(136 aa)
未记录 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 7.5;298 K;0.1M Hepes pH 7.5, 0.2M Lithium Sulfate, 0.1M Sodium Acetate, 25% (w/v) PEG 4000, temperature 298K
分辨率 2.23 Å R-free 0.225
4XBQ Crystal Structure of Human Galectin-7 in Complex with Type 1 N-acetyllactosamine 提交 2014-12-17 Assembly 2 其他组合 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 1–136(136 aa)
未记录 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 7.5;298 K;0.1M Hepes pH 7.5, 0.2M Lithium Sulfate, 0.1M Sodium Acetate, 25% (w/v) PEG 4000, temperature 298K
分辨率 2.23 Å R-free 0.225
4Y26 Complex of human Galectin-7 and Galbeta1-3(6OSO3)GlcNAc 提交 2015-02-09 Assembly 1 其他组合 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 4–136(133 aa)
链 B 4–136(133 aa)
未记录 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 7.5;298 K;0.1M HEPES (pH 7.5), 0.2M Li2SO4, 0.1M NaOAc, 25% (w/v) PEG 4000
分辨率 2.61 Å R-free 0.258
5GAL CRYSTAL STRUCTURE OF HUMAN GALECTIN-7 IN COMPLEX WITH N-ACETYLLACTOSAMINE 提交 1998-07-14 Assembly 1 其他组合 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 1–135(135 aa)
链 B 1–135(135 aa)
未记录 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 8.1;CRYSTALS WERE GROWN USING THE HANGING DROP METHOD FROM DROPS CONTAINING 9 MG/ML PROTEIN AT PH 8.1 IN 50 MM SODIUM PHOSPHATE BUFFER, 0.3 M SODIUM CHLORIDE, 20 MM IMIDAZOLE, 8.5% PEG 3350. DROPS WERE EQUILIBRATED AGAINST RESERVOIRS CONTAINING 50 MM SODIUM PHOSPHATE BUFFER, 0.3 M SODIUM CHLORIDE, 20 MM IMIDAZOLE, 17% PEG 3350. GALECTIN-7 CRYSTALS WERE THEN SOAKED WITH 50 MM N-ACETYLLACTOSAMINE FOR 3 DAYS., vapor diffusion - hanging drop
分辨率 2.00 Å R-free 0.296
5H9Q Crystal Structure of Human Galectin-7 in Complex with TD139 提交 2015-12-29 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 1–136(136 aa)
链 B 1–136(136 aa)
未记录 TD2 3-deoxy-3-[4-(3-fluorophenyl)-1H-1,2,3-triazol-1-yl]-beta-D-galactopyranosyl 3-deoxy-3-[4-(3-fluorophenyl)-1H-1,2,3-triazol-1-yl]-1-thio-beta-D-galactopyranoside × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 8;298 K;0.22 M Mg Acetate, 21% (w/v) PEG3350
分辨率 1.93 Å R-free 0.238
5H9S Crystal Structure of Human Galectin-7 in Complex with TAZTDG 提交 2015-12-29 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 1–136(136 aa)
链 B 1–136(136 aa)
未记录 TGZ (2~{S},3~{R},4~{S},5~{R},6~{R})-2-[(2~{S},3~{R},4~{S},5~{R},6~{R})-4-[4-(3-fluorophenyl)-1,2,3-triazol-1-yl]-6-(hydroxymethyl)-3,5-bis(oxidanyl)oxan-2-yl]sulfanyl-6-(hydroxymethyl)oxane-3,4,5-triol × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 8;298 K;0.22 M MgAcetate, 21% (w/v) PEG 3350
分辨率 1.82 Å R-free 0.227
6VTO Crystal structure of human Galectin-7 in complex with 4-O-beta-D-Galactopyranosyl-D-glucose 提交 2020-02-13 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 2–136(135 aa)
链 B 2–136(135 aa)
未记录 LBL (2~{R},3~{R},4~{R},5~{R})-4-[(2~{S},3~{R},4~{S},5~{R},6~{R})-6-(hydroxymethyl)-3,4,5-tris(oxidanyl)oxan-2-yl]oxy-2,3,5, 6-tetrakis(oxidanyl)hexanal × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 8;295 K;0.1 M Sodium Chloride, 0.1 M Tris pH 8, 20 % PEG3350, 5 % Glycerol
分辨率 1.69 Å R-free 0.215
6VTP Crystal structure of G16C human Galectin-7 mutant 提交 2020-02-13 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 2–136(135 aa)
链 B 2–136(135 aa)
突变:G16C 突变:G16C GOL GLYCEROL × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 8;295.15 K;0.1 M Sodium chloride, 0.1M Tris pH 8, 20 % PEG 3350, 15 % Glycerol
分辨率 2.30 Å R-free 0.261
6VTQ Crystal structure of G16C human Galectin-7 mutant in complex with lactose 提交 2020-02-13 Assembly 1 其他组合 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 2–136(135 aa)
链 B 2–136(135 aa)
突变:G16C 非标准单体:是(mmCIF未提供具体位点) 突变:G16C 非标准单体:是(mmCIF未提供具体位点) GOL GLYCEROL × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 8;295.15 K;0.1 M Tris pH 8, 0.1 M Sodium Chloride, 25 % PEG3350, 7.5 mM alpha-lactose
分辨率 1.95 Å R-free 0.244
6VTR Crystal structure of G16S human Galectin-7 mutant 提交 2020-02-13 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 2–136(135 aa)
链 B 2–136(135 aa)
突变:G16S 突变:G16S TRS 2-AMINO-2-HYDROXYMETHYL-PROPANE-1,3-DIOL × 1 GOL GLYCEROL × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 8;295.15 K;0.1 M NaCl, 0.1 M Tris pH 8.0, 20 % PEG 3350, 17.5 % Glycerol
分辨率 2.30 Å R-free 0.256
6VTS Crystal structure of G16S human Galectin-7 mutant in complex with lactose 提交 2020-02-13 Assembly 1 其他组合 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 2–136(135 aa)
链 B 2–136(135 aa)
突变:G16S 突变:G16S GOL GLYCEROL × 3 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 8;295.15 K;0.1 M Tris pH 8, 0.1 M NaCl, 16 % PEG 3350, 150 mM alpha-Lactose
分辨率 1.90 Å R-free 0.221
7N4O Crystal structure of R20A human Galectin-7 mutant 提交 2021-06-04 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 2–136(135 aa)
链 B 2–136(135 aa)
突变:R20A 突变:R20A 非标准单体:是(mmCIF未提供具体位点) EDO 1,2-ETHANEDIOL × 1 GOL GLYCEROL × 4 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 8;295.15 K;0.1 M NaCl, 0.1 M Tris pH 8, 20 % PEG 6000 , 20% Glycerol
分辨率 2.05 Å R-free 0.252
7N57 Crystal structure of R20A human Galectin-7 mutant in presence of lactose 提交 2021-06-04 Assembly 1 其他组合 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 2–136(135 aa)
链 B 2–136(135 aa)
突变:R20A 突变:R20A GOL GLYCEROL × 1 EDO 1,2-ETHANEDIOL × 3 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;293.15 K;0.2M Sodium chloride, 0.1M Tris pH 8.0, 20% w/v PEG 6000
分辨率 1.83 Å R-free 0.208
7N6C Crystal structure of R22A human Galectin-7 mutant 提交 2021-06-08 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 2–136(135 aa)
链 B 2–136(135 aa)
突变:R22A 突变:R22A GOL GLYCEROL × 3 TRS 2-AMINO-2-HYDROXYMETHYL-PROPANE-1,3-DIOL × 1 EDO 1,2-ETHANEDIOL × 5 PEG DI(HYDROXYETHYL)ETHER × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 8;295.15 K;0.1 M NaCl, 0.1 M Tris pH 8, 20 % PEG 6000, 17.5% Glycerol
分辨率 2.10 Å R-free 0.235
7N8D Crystal structure of R22A human Galectin-7 mutant in presence of Lactose 提交 2021-06-14 Assembly 1 其他组合 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 2–136(135 aa)
链 B 2–136(135 aa)
突变:R22A 突变:R22A 非标准单体:是(mmCIF未提供具体位点) EDO 1,2-ETHANEDIOL × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 8;295.15 K;0.1 M NaCl, 0.1 M Tris pH 8, 20 % PEG 6000, 7.5 mM alpha Lactose
分辨率 2.49 Å R-free 0.281
7N8G Crystal structure of R20A-R22A human Galectin-7 mutant 提交 2021-06-14 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 2–136(135 aa)
链 B 2–136(135 aa)
突变:R20A, R22A 突变:R20A, R22A EDO 1,2-ETHANEDIOL × 3 TRS 2-AMINO-2-HYDROXYMETHYL-PROPANE-1,3-DIOL × 1 GOL GLYCEROL × 5 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 8;295.15 K;0.1 M NaCl, 0.1 M Tris pH 8, 20 % PEG 6000 ,17.5% Glycerol
分辨率 1.95 Å R-free 0.204
7N96 Crystal structure of D103A human Galectin-7 mutant 提交 2021-06-16 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 2–136(135 aa)
链 B 2–136(135 aa)
突变:D103A 突变:D103A GOL GLYCEROL × 3 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 8;295.15 K;0.1 M NaCl, 0.1 M Tris pH 8, 20 % PEG 6000 ,15% Glycerol
分辨率 2.38 Å R-free 0.259
7RDG Crystal structure of D103A human Galectin-7 mutant in presence of lactose 提交 2021-07-09 Assembly 1 其他组合 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 C 2–136(135 aa)
链 D 2–136(135 aa)
突变:D103A 突变:D103A EDO 1,2-ETHANEDIOL × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 7.3;295.15 K;0.1 M Tris pH 7.3, 0.1 M NaCl, 18% P400, 26% PEG 3350
分辨率 3.00 Å R-free 0.268
7RDG Crystal structure of D103A human Galectin-7 mutant in presence of lactose 提交 2021-07-09 Assembly 2 其他组合 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 2–136(135 aa)
链 B 2–136(135 aa)
突变:D103A 突变:D103A EDO 1,2-ETHANEDIOL × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 7.3;295.15 K;0.1 M Tris pH 7.3, 0.1 M NaCl, 18% P400, 26% PEG 3350
分辨率 3.00 Å R-free 0.268
7TKW Crystal structure of R14A human Galectin-7 mutant 提交 2022-01-17 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 2–136(135 aa)
链 B 2–136(135 aa)
突变:R14A 突变:R14A GOL GLYCEROL × 4 PEG DI(HYDROXYETHYL)ETHER × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 8;295.15 K;0.2 M Sodium chloride, 0.1 M Tris 8.0, 20 % w/v PEG 6000
分辨率 1.85 Å R-free 0.231
7TKX Crystal structure of R14A human Galectin-7 mutant in presence of 4-O-beta-D-Galactopyranosyl-D-glucose 提交 2022-01-17 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 2–136(135 aa)
链 B 2–136(135 aa)
突变:R14A 突变:R14A LBL (2~{R},3~{R},4~{R},5~{R})-4-[(2~{S},3~{R},4~{S},5~{R},6~{R})-6-(hydroxymethyl)-3,4,5-tris(oxidanyl)oxan-2-yl]oxy-2,3,5, 6-tetrakis(oxidanyl)hexanal × 2 EDO 1,2-ETHANEDIOL × 4 GOL GLYCEROL × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 8;295.15 K;0.1 M NaCl, 0.1 M Tris pH 8, 20 % PEG 6000, 10% Glycerol
分辨率 1.83 Å R-free 0.213
7TKY Crystal structure of D94A human Galectin-7 mutant 提交 2022-01-17 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 2–136(135 aa)
链 B 2–136(135 aa)
突变:D94A 突变:D94A GOL GLYCEROL × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;295.15 K;0.1 M NaCl, 0.1 M Tris pH 8, 20 % PEG 6000, 15% Glycerol
分辨率 2.53 Å R-free 0.283
7TKZ Crystal structure of D94A human Galectin-7 mutant in presence of lactose 提交 2022-01-17 Assembly 1 其他组合 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 2–136(135 aa)
链 B 2–136(135 aa)
突变:D94A 非标准单体:是(mmCIF未提供具体位点) 突变:D94A 非标准单体:是(mmCIF未提供具体位点) EDO 1,2-ETHANEDIOL × 1 PEG DI(HYDROXYETHYL)ETHER × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;295.15 K;0.1 M NaCl, 0.1 M Tris pH 8.0, 20 % PEG 6000, 15% glycerol, 7.5 mM Lactose
分辨率 1.83 Å R-free 0.225
7TRN Crystal structure of R14A-R20A human Galectin-7 mutant 提交 2022-01-29 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 2–136(135 aa)
链 B 2–136(135 aa)
突变:R14A, R20A 突变:R14A, R20A GOL GLYCEROL × 3 EDO 1,2-ETHANEDIOL × 11 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 8;295.15 K;0.1 M NaCl, 0.1 M Tris pH 8, 20 % PEG 6000, 17.5% Glycerol
分辨率 1.95 Å R-free 0.225
7TRN Crystal structure of R14A-R20A human Galectin-7 mutant 提交 2022-01-29 Assembly 2 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 C 2–136(135 aa)
链 D 2–136(135 aa)
突变:R14A, R20A 突变:R14A, R20A EDO 1,2-ETHANEDIOL × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 8;295.15 K;0.1 M NaCl, 0.1 M Tris pH 8, 20 % PEG 6000, 17.5% Glycerol
分辨率 1.95 Å R-free 0.225
7TRO Crystal structure of R14A-R20A human Galectin-7 mutant in presence of lactose 提交 2022-01-29 Assembly 1 其他组合 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 2–136(135 aa)
链 B 2–136(135 aa)
突变:R14A, R20A 突变:R14A, R20A EDO 1,2-ETHANEDIOL × 1 TRS 2-AMINO-2-HYDROXYMETHYL-PROPANE-1,3-DIOL × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 8;295.15 K;0.1 M NaCl,0.1 M Tris pH 8, 20 % PEG 6000, 5% Glycerol, 7.5 mM Lactose
分辨率 1.80 Å R-free 0.221
7XAC Dimeric structure of human galectin-7 in complex with two glycerol 提交 2022-03-17 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 1–136(136 aa)
链 B 1–136(136 aa)
未记录 GOL GLYCEROL × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;293 K;20% PEG 3350, 0.2M Magnesium chloride, 0.1M Hepes pH7.5
分辨率 1.80 Å R-free 0.253
7XBL Dimeric structure of human galectin-7 in complex with three glycerol 提交 2022-03-21 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 1–136(136 aa)
链 B 1–136(136 aa)
未记录 GOL GLYCEROL × 3 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;298 K;0.1M Hepes pH7.5, 12% PEG 3350
分辨率 2.00 Å R-free 0.222